- DKK20.84bn
- DKK20.71bn
- DKK6.04bn
Brief: Ambu Q3 Revenue DKK 1,383 Million
JPM ups Ambu on balanced risks, improving business profile
Europe Research Roundup: ABB Ltd, Capital & Regional Plc, Neste Oyj
Brief: Ambu Maintains Adjusted FY 2023/24 Financial Guidance
Brief: Ambu Q2 Adjusted EBIT DKK 194 Million Vs. Estimate DKK 194 Million
Brief: Ambu Gets FDA Clearance For Generation Duodenoscopy Solution
Outlook hike sends Ambu shares up
Brief: Ambu Obtains FDA Clearance For Single-Use Therapeutic Gastroscope
Europe Research Roundup: Antofagasta, Rational AG, Spirax-Sarco
Ambu jumps as soaring endoscopy sales drive Q1 beat
Brief: Ambu Maintains 2023/24 Financial Guidance
Brief: Ambu Q1 Adjusted EBIT DKK 126 Million Vs. Estimate DKK 105 Million
Brief: Ambu Obtains CE Mark Of Ureteroscopy Solution
Europe Research Roundup: Anglo American, Marks and Spencer, Vestas
Brief: Ambu Upgrades Its Full-Year EBIT Margin
Brief: Ambu Q4 Adjusted EBIT DKK 97 Million Vs. Estimate DKK 97 Million
Brief: Ambu Outlook FY Adjusted EBIT Margin 8-10%
Brief: Ambu Plans For Integrating Bioplastics Across Its Full Portfolio Of Endoscopes
Brief: Ambu APPOINTS NEW CHIEF FINANCIAL OFFICER